← Back to Clinical Trials
Recruiting NCT05486546

Contoura With Phorcides Compared to Wavefront Optimized LASIK

Trial Parameters

Condition Myopia
Sponsor Daniel Terveen
Study Type INTERVENTIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 21 Years
Max Age 38 Years
Start Date 2022-08-15
Completion 2023-09-01
All Conditions
Interventions
Contoura with PhorcidesWaveLight Wavefront Optimized

Brief Summary

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Eligibility Criteria

Inclusion Criteria: * Patients at least age 21 years of age undergoing LASIK eye surgery * Willing and able to comprehend informed consent and complete 1 month post-op visit * Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion * Candidates for Contoura with Phorcides (Myopic, astigmatism \<3.0D) * Both eyes targeted for plano * Pre-operative total corneal Pachymetry 490um or above * Stable refractive error \<0.50D change in preceding year * Good general and ocular health * Pre-operative exam completed within three months of surgery * SCL discontinued 3 days prior to pre-op exam and the procedure * Pachymetry above 490 with residual greater than 270um * Candidates who, as determined by the investigator, can safely undergo LASIK Exclusion Criteria: * Patients under 21 years of age * Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon * Patients with usual relative and absolute contraindications for LAS

Related Trials